AMG334

· Amgen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AMG334, covering 2022-10-25 to 2022-10-25. Get the full timeline:

Most recent: Clinical Trial Update: Study of Sustained Benefit of AMG334 in Adult Episodic Migraine Patients [Phase 4]